These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11711314)

  • 1. Synthesis and in vivo evaluation of [11C]methyl-Ro 64-6198 as an ORL1 receptor imaging agent.
    Ogawa M; Hatano K; Kawasumi Y; Wichmann J; Ito K
    Nucl Med Biol; 2001 Nov; 28(8):941-7. PubMed ID: 11711314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological characterization of the novel nonpeptide orphanin FQ/nociceptin receptor agonist Ro 64-6198: rapid and reversible desensitization of the ORL1 receptor in vitro and lack of tolerance in vivo.
    Dautzenberg FM; Wichmann J; Higelin J; Py-Lang G; Kratzeisen C; Malherbe P; Kilpatrick GJ; Jenck F
    J Pharmacol Exp Ther; 2001 Aug; 298(2):812-9. PubMed ID: 11454946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ro 64-6198 [(1S,3aS)-8-(2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one] acts differently from nociceptin/orphanin FQ in rat periaqueductal gray slices.
    Chiou LC; Chuang KC; Wichmann J; Adam G
    J Pharmacol Exp Ther; 2004 Nov; 311(2):645-51. PubMed ID: 15254141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of (1S,3aS)-8-(2,3,3a,4,5, 6-hexahydro-1H-phenalen-1-yl)-1-phenyl-1,3,8-triaza-spiro[4. 5]decan-4-one, a potent and selective orphanin FQ (OFQ) receptor agonist with anxiolytic-like properties.
    Wichmann J; Adam G; Röver S; Hennig M; Scalone M; Cesura AM; Dautzenberg FM; Jenck F
    Eur J Med Chem; 2000 Sep; 35(9):839-51. PubMed ID: 11006485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The opioid receptor like-1 receptor agonist Ro 64-6198 (1S,3aS-8-2,3,3a,4,5,6-hexahydro-1H-phenalen-1-yl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one) produces a discriminative stimulus in rats distinct from that of a mu, kappa, and delta opioid receptor agonist cue.
    Recker MD; Higgins GA
    J Pharmacol Exp Ther; 2004 Nov; 311(2):652-8. PubMed ID: 15226383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of nociceptin and Ro64-6198 activated [35S]-GTPgammaS binding in the rat brain.
    Gehlert DR; Gackenheimer SL; Shaw JL
    Neuropeptides; 2006 Apr; 40(2):95-105. PubMed ID: 16403422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of LC-MS/MS-based receptor occupancy tracers and positron emission tomography radioligands for the nociceptin/orphanin FQ (NOP) receptor.
    Pedregal C; Joshi EM; Toledo MA; Lafuente C; Diaz N; Martinez-Grau MA; Jiménez A; Benito A; Navarro A; Chen Z; Mudra DR; Kahl SD; Rash KS; Statnick MA; Barth VN
    J Med Chem; 2012 Jun; 55(11):4955-67. PubMed ID: 22541041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Synthesis and Pharmacological Characterization of NOP Receptor Agonist 8-[(1S,3aS)-2,3,3a,4,5,6-Hexahydro-1H-phenalen-1-yl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one (Ro 64-6198).
    Chang SD; Brieaddy LE; Harvey JD; Lewin AH; Mascarella SW; Seltzman HH; Reddy PA; Decker AM; McElhinny CJ; Zhong D; Peterson EE; Navarro HA; Bruchas MR; Carroll FI
    ACS Chem Neurosci; 2015 Dec; 6(12):1956-64. PubMed ID: 26367173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of stress- and CRF-induced anorexia in rats by the synthetic nociceptin/orphanin FQ receptor agonist, Ro 64-6198.
    Ciccocioppo R; Biondini M; Antonelli L; Wichmann J; Jenck F; Massi M
    Psychopharmacology (Berl); 2002 May; 161(2):113-9. PubMed ID: 11981590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-affinity, non-peptide agonists for the ORL1 (orphanin FQ/nociceptin) receptor.
    Röver S; Adam G; Cesura AM; Galley G; Jenck F; Monsma FJ; Wichmann J; Dautzenberg FM
    J Med Chem; 2000 Apr; 43(7):1329-38. PubMed ID: 10753470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat.
    Jenck F; Wichmann J; Dautzenberg FM; Moreau JL; Ouagazzal AM; Martin JR; Lundstrom K; Cesura AM; Poli SM; Roever S; Kolczewski S; Adam G; Kilpatrick G
    Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4938-43. PubMed ID: 10758169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.
    Witkin JM; Statnick MA; Rorick-Kehn LM; Pintar JE; Ansonoff M; Chen Y; Tucker RC; Ciccocioppo R
    Pharmacol Ther; 2014 Mar; 141(3):283-99. PubMed ID: 24189487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of 1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidyl]-3-[11C]ethyl-1,3-dihydro-2H-benzimidazol-2-one as a brain ORL1 receptor imaging agent for positron emission tomography.
    Ogawa M; Hatano K; Kawasumi Y; Ishiwata K; Kawamura K; Ozaki S; Ito K
    Nucl Med Biol; 2003 Jan; 30(1):51-9. PubMed ID: 12493543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo evaluation of [123I]-8-[4-[2-(5-iodothienyl)]-4-oxobutyl]-3-methyl-1-phenyl-1,3 ,8-tri azaspiro[4.5]decan-4-one as a potential dopamine D2 receptor radioligand for SPECT.
    Waterhouse RN; Gotsick JT; Kabalka GW; Goodman MM; O'Brien JC
    Nucl Med Biol; 1998 Jan; 25(1):77-80. PubMed ID: 9466366
    [No Abstract]   [Full Text] [Related]  

  • 15. Acquisition, expression, and reinstatement of ethanol-induced conditioned place preference in mice: effects of opioid receptor-like 1 receptor agonists and naloxone.
    Kuzmin A; Sandin J; Terenius L; Ogren SO
    J Pharmacol Exp Ther; 2003 Jan; 304(1):310-8. PubMed ID: 12490606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of [¹⁸F]MK-0911, a positron emission tomography (PET) tracer for opioid receptor-like 1 (ORL1), in rhesus monkey and human.
    Hostetler ED; Sanabria-Bohórquez S; Eng W; Joshi AD; Patel S; Gibson RE; O'Malley S; Krause SM; Ryan C; Riffel K; Bi S; Okamoto O; Kawamoto H; Ozaki S; Ohta H; de Groot T; Bormans G; Depré M; de Hoon J; De Lepeleire I; Reynders T; Cook JJ; Burns HD; Egan M; Cho W; van Laere K; Hargreaves RJ
    Neuroimage; 2013 Mar; 68():1-10. PubMed ID: 23238431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (8-Naphthalen-1-ylmethyl-4-oxo-1-phenyl-1,3,8-triaza-spiro[4. 5]dec-3-yl)-acetic acid methyl ester (NNC 63-0532) is a novel potent nociceptin receptor agonist.
    Thomsen C; Hohlweg R
    Br J Pharmacol; 2000 Nov; 131(5):903-8. PubMed ID: 11053209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 8-acenaphthen-1-yl-1-phenyl-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as orphanin FQ receptor agonists.
    Wichmann J; Adam G; Röver S; Cesura AM; Dautzenberg FM; Jenck F
    Bioorg Med Chem Lett; 1999 Aug; 9(16):2343-8. PubMed ID: 10476866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the selective ORL1 receptor agonist, Ro64-6198, on rodent neurological function.
    Higgins GA; Grottick AJ; Ballard TM; Richards JG; Messer J; Takeshima H; Pauly-Evers M; Jenck F; Adam G; Wichmann J
    Neuropharmacology; 2001 Jul; 41(1):97-107. PubMed ID: 11445190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occupancy of Nociceptin/Orphanin FQ Peptide Receptors by the Antagonist LY2940094 in Rats and Healthy Human Subjects.
    Raddad E; Chappell A; Meyer J; Wilson A; Ruegg CE; Tauscher J; Statnick MA; Barth V; Zhang X; Verfaille SJ
    Drug Metab Dispos; 2016 Sep; 44(9):1536-42. PubMed ID: 27353045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.